These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Long-term therapy with clopidogrel in combination with ASA significantly reduces risk of death, myocardial infarct or stroke]. Minerva Med; 2003 Apr; 94(2):XIII-IV. PubMed ID: 12916522 [No Abstract] [Full Text] [Related]
4. [Antiplatelet drugs in prevention and treatment of coronary heart disease: aspirin is obligatory, quite sufficient, and safe]. Averkov OV Kardiologiia; 2003; 43(6):77-83. PubMed ID: 13677327 [No Abstract] [Full Text] [Related]
5. Aspirin + clopidogrel therapy: how does your care compare to the evidence? Simmons BB; Salzman BE J Fam Pract; 2008 Jan; 57(1):26-32. PubMed ID: 18171566 [No Abstract] [Full Text] [Related]
6. Antiplatelet therapy after placement of a drug-eluting stent: a review of efficacy and safety studies. Mohammad RA; Goldberg T; Dorsch MP; Cheng JW Clin Ther; 2010 Dec; 32(14):2265-81. PubMed ID: 21353100 [TBL] [Abstract][Full Text] [Related]
7. Platelet activation and atherothrombosis. Kapoor JR N Engl J Med; 2008 Apr; 358(15):1638; author reply 1638-9. PubMed ID: 18403776 [No Abstract] [Full Text] [Related]
13. [Combination is standard. Dual thrombocyte function inhibition in acute coronary syndrome]. MMW Fortschr Med; 2004; 146 Suppl 1():8-9. PubMed ID: 15493411 [No Abstract] [Full Text] [Related]
14. Concurrent antiplatelet and fibrinolytic therapy. Lange RA; Hillis LD N Engl J Med; 2005 Mar; 352(12):1248-50. PubMed ID: 15758001 [No Abstract] [Full Text] [Related]
15. [Myocardial infarct, stroke and vascular events reduced by a third]. Z Kardiol; 1997 Nov; 86(11 Suppl Myokardinf):1-3. PubMed ID: 9437253 [No Abstract] [Full Text] [Related]
16. Selecting the optimal stroke prevention therapy in atrial fibrillation. Fang MC Ann Intern Med; 2011 Nov; 155(9):636-7. PubMed ID: 22041953 [No Abstract] [Full Text] [Related]
17. [Aspirin vs ticlid and their combination in patients with acute myocardial infarction]. Vyshlov EV; Panfilova EV; Markov VA Klin Med (Mosk); 2000; 78(1):37-9. PubMed ID: 10697373 [TBL] [Abstract][Full Text] [Related]
18. Comment: mortality benefit of no-load clopidogrel in COMMIT: not a surprise. Serebruany VL J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):99-100. PubMed ID: 16703225 [No Abstract] [Full Text] [Related]
19. [Interview with Prof. Dr. H. J. Rupprecht about secondary prevention: what is the optimal thrombocyte function inhibition?]. Rupprecht HJ MMW Fortschr Med; 2004; 146 Suppl 1():9-10. PubMed ID: 15493412 [No Abstract] [Full Text] [Related]
20. [Does dual antiplatelet therapy always require gastroprotection? Tailored medical therapy should prevail over the generalized prescription of proton pump inhibitors in patients on dual antiplatelet therapy]. Marcucci R G Ital Cardiol (Rome); 2010 Jun; 11(6):481-7; discussion 487. PubMed ID: 20922874 [No Abstract] [Full Text] [Related] [Next] [New Search]